Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: JMarcus who wrote (210)	1/16/2003 12:08:07 PM
From: Jibacoa	Read Replies (2) \| Respond to of 3722

NTII Yes, it needs to close above the December 16 H of 6.88 That would be another 52 wks H and will probably let it test its November 2000 H at 7.25 <g> The stock is somewhat stranded for cash.($0.08 cash/share) albeit its last Q loss was $0 and they have started to receive income after the approval in Europe of Memantine for the treatment of Alzheimer's disease. FRX submitted to the FDA an NDA in December for memantine. If the drug gets approval in the US that would be good news for NTII.<g> The stock is still selling at more than 19x book and institutions reportedly have been doing some selling. siliconinvestor.com siliconinvestor.com Bernard